Diligence memo · auto-generated · as of July 2, 2026
RecoMed
RecoMed looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
RecoMed operates in Healthtech, based in Africa. SA e-health startup RecoMed secures $324k investment 0 By Tom Jackson on November 23, 2017 News , Southern Africa South African e-health startup RecoMed has raised ZAR4.5 million (US$324,000) in funding to fund a shift to increasing product traction and market its products and services. RecoMed is an online healthcare marketplace, enabling consumers to easily book appointments with a diverse group of healthcare providers 24/7, who in turn benefit from increased patient traffic and practice efficiencies.
Sub-sector tags: healthtech.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
RecoMed has raised $324K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $324K on 2017-11-23.
Most recent recorded round closed around 2017-11-23.
Valuation (modeled)modeled
Provath models RecoMed at approximately $11M (range $203K–$127M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.81× the median modeled value of Pre-Seed Healthtech companies in 2016–2018 (113 peers) — value vs value, same stage and era. Within the normal band (81% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 8.6 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 17% of Healthtech peers (2138 compared).
Modeled value ranks above 35% of those peers.
Closest niche peers: Nulogix Health, Inc., HealthTech Solutions, Inc., Caddo Medical Technologies LLC, Markit Medical, Inc., Unique Medical Services, LLC.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.